CY1119228T1 - Ιατρικα δραστικο εμπλαστρο - Google Patents
Ιατρικα δραστικο εμπλαστροInfo
- Publication number
- CY1119228T1 CY1119228T1 CY20171100881T CY171100881T CY1119228T1 CY 1119228 T1 CY1119228 T1 CY 1119228T1 CY 20171100881 T CY20171100881 T CY 20171100881T CY 171100881 T CY171100881 T CY 171100881T CY 1119228 T1 CY1119228 T1 CY 1119228T1
- Authority
- CY
- Cyprus
- Prior art keywords
- layer
- carrier layer
- etofenamate
- administration
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Ιατρικό έμπλαστρο για την χορήγηση στο δέρμα υγρών σε θερμοκρασία δωματίου φαρμακευτικών δραστικών ουσιών, ειδικότερα για την χορήγηση της αντιφλεγμονώδους δράσης δραστικής ουσίας Ετοφαιναμάτη, όπου αυτό το έμπλαστρο παρουσιάζει μία δομή σύμφωνα προς το Σχήμα 1, όπου η καλυπτική στρώση (a) αποτελείται από ένα αδρανές υλικό, η φέρουσα στρώση (c) αποτελείται από ένα αυτοκόλλητο πολυσιλοξάνιο εντός του οποίου αποθηκεύεται η αντιφλεγμονώδους δράσης δραστική ουσία, κατά προτίμηση Ετοφαιναμάτη, ενδεχομένως μαζί με ένα μέσο το οποίο προάγει τη διείσδυση μέσω του δέρματος και ενδεχομένως επιπλέον πρόσθετα υπό τη μορφή μιας διασποράς, όπου η φέρουσα στρώση (c) προσφύεται άμεσα στην καλυπτική στρώση (a) ή ενδεχομένως συνδέεται με αυτήν μέσω της ενδιάμεσης στρώσης (c)· και η αποκολλούμενη προστατευτική στρώση (d) αποτελείται από ένα αδρανές υλικό, προσφύεται στη φέρουσα στρώση (c) και αποκολλάται εύκολα από αυτήν.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH332007 | 2007-01-11 | ||
CH8712007 | 2007-05-31 | ||
PCT/CH2008/000010 WO2008083508A1 (de) | 2007-01-11 | 2008-01-10 | Medizinisch wirksames pflaster |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1119228T1 true CY1119228T1 (el) | 2018-02-14 |
Family
ID=39145243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100881T CY1119228T1 (el) | 2007-01-11 | 2017-08-18 | Ιατρικα δραστικο εμπλαστρο |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2120896B8 (el) |
KR (1) | KR101495577B1 (el) |
AU (1) | AU2008204710C1 (el) |
BR (1) | BRPI0806462A2 (el) |
CA (1) | CA2674681C (el) |
CY (1) | CY1119228T1 (el) |
DK (1) | DK2120896T3 (el) |
ES (1) | ES2638000T3 (el) |
HR (1) | HRP20171260T1 (el) |
IL (1) | IL199756A (el) |
MX (1) | MX2009007408A (el) |
MY (1) | MY148823A (el) |
NZ (1) | NZ578323A (el) |
PL (1) | PL2120896T3 (el) |
PT (1) | PT2120896T (el) |
SG (1) | SG177971A1 (el) |
SI (1) | SI2120896T1 (el) |
WO (1) | WO2008083508A1 (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3037779B1 (fr) * | 2015-06-29 | 2018-11-23 | L V M H Recherche | Article pour decorer la peau ou un ongle d'un humain et procede mettant en œuvre un tel article |
CH718851A1 (de) | 2021-07-26 | 2023-01-31 | Drossapharm Ag | Zusammensetzung geeignet für die Herstellung eines medizinisch wirksamen Pflasters. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3344691A1 (de) * | 1983-12-10 | 1985-06-20 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgasesysteme |
DE3347277A1 (de) * | 1983-12-28 | 1985-07-11 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgabesysteme |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
CA2161004C (en) * | 1993-04-20 | 2004-10-26 | Wilfried Fischer | Active ingredient patch |
DE4332094C2 (de) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung |
US6316022B1 (en) * | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
US20060263419A1 (en) * | 2002-03-12 | 2006-11-23 | Hans-Michael Wolff | Transdermal therapeutic system for Parkinson's Disease |
ES2536478T3 (es) * | 2004-12-15 | 2015-05-25 | Teikoku Seiyaku Co., Ltd. | Parches externos que contienen etofenamato |
-
2008
- 2008-01-10 PL PL08700515T patent/PL2120896T3/pl unknown
- 2008-01-10 MX MX2009007408A patent/MX2009007408A/es active IP Right Grant
- 2008-01-10 CA CA2674681A patent/CA2674681C/en active Active
- 2008-01-10 EP EP08700515.3A patent/EP2120896B8/de active Active
- 2008-01-10 MY MYPI20092891A patent/MY148823A/en unknown
- 2008-01-10 SG SG2012002168A patent/SG177971A1/en unknown
- 2008-01-10 DK DK08700515.3T patent/DK2120896T3/en active
- 2008-01-10 NZ NZ578323A patent/NZ578323A/en unknown
- 2008-01-10 KR KR1020097015753A patent/KR101495577B1/ko active IP Right Grant
- 2008-01-10 PT PT87005153T patent/PT2120896T/pt unknown
- 2008-01-10 AU AU2008204710A patent/AU2008204710C1/en active Active
- 2008-01-10 WO PCT/CH2008/000010 patent/WO2008083508A1/de active Application Filing
- 2008-01-10 ES ES08700515.3T patent/ES2638000T3/es active Active
- 2008-01-10 BR BRPI0806462-8A patent/BRPI0806462A2/pt not_active Application Discontinuation
- 2008-01-10 SI SI200831851T patent/SI2120896T1/sl unknown
-
2009
- 2009-07-08 IL IL199756A patent/IL199756A/en active IP Right Grant
-
2017
- 2017-08-17 HR HRP20171260TT patent/HRP20171260T1/hr unknown
- 2017-08-18 CY CY20171100881T patent/CY1119228T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008204710B2 (en) | 2013-01-10 |
EP2120896A1 (de) | 2009-11-25 |
BRPI0806462A2 (pt) | 2011-09-06 |
SG177971A1 (en) | 2012-02-28 |
NZ578323A (en) | 2011-12-22 |
IL199756A0 (en) | 2010-04-15 |
EP2120896B1 (de) | 2017-05-24 |
IL199756A (en) | 2014-03-31 |
PL2120896T3 (pl) | 2017-10-31 |
KR20090099076A (ko) | 2009-09-21 |
EP2120896B8 (de) | 2017-08-23 |
DK2120896T3 (en) | 2017-09-11 |
SI2120896T1 (sl) | 2017-10-30 |
WO2008083508A1 (de) | 2008-07-17 |
MY148823A (en) | 2013-06-14 |
PT2120896T (pt) | 2017-08-30 |
ES2638000T3 (es) | 2017-10-18 |
KR101495577B1 (ko) | 2015-02-25 |
CA2674681C (en) | 2014-12-02 |
AU2008204710A1 (en) | 2008-07-17 |
HRP20171260T1 (hr) | 2017-10-20 |
CA2674681A1 (en) | 2008-07-17 |
MX2009007408A (es) | 2009-07-17 |
AU2008204710C1 (en) | 2013-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123712T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
CY1120283T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης | |
BR112013009609A2 (pt) | microagulhas à base de fibroína de seda e métodos para fazer os mesmos | |
CY1120964T1 (el) | Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακων | |
BR112015005944A2 (pt) | dispositivo de entrega de fármaco transdérmico | |
EA201190300A1 (ru) | Микроэлектрод и множественные микроэлектроды, содержащие устройства для высвобождения лекарственных средств в ткани | |
UY29020A1 (es) | Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina, procedimientos para su preparacinn y su uso.- | |
MX2019011434A (es) | Dispositivo de aseguramiento de cateter con ventana. | |
CY1109954T1 (el) | Διαδερμικο θεραπευτικο συστημα (tts) με τη δραστικη ουσια φεντανυλη | |
MX2009012273A (es) | Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica. | |
ATE429908T1 (de) | Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion. | |
CY1112738T1 (el) | Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη | |
ATE389432T1 (de) | Vorrichtung zur transdermalen verabreichung von wirkstoffen | |
MY163809A (en) | Transdermal drug delivery system containing donepezil | |
AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
DE502007003630D1 (de) | Transdermales therapeutisches system mit ionenpaar-mikroreservoiren | |
CY1119228T1 (el) | Ιατρικα δραστικο εμπλαστρο | |
CO6640324A2 (es) | Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa | |
MY161056A (en) | Dental strip for administration of oral treatment | |
EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
BR112012014107A2 (pt) | sistema terapêutico transdérmico para administração de peptídeos | |
CY1115757T1 (el) | Στερεο διαδερμικο θεραπευτικο συστημα που περιλαμβανει uv-απορροφητη | |
Zhao et al. | The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system | |
MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
DK2257254T3 (da) | Plaster |